There's a secondary consideration as well; designing new chemicals is fairly easy, synthesizing them harder, and scaling that to commercial manufacturing very hard.
Oh, and you still have to prove it to be safe and effective through years of clinical trials.
AI is basically still only helping us with the easiest parts, and this particular class is drugs is essentially a limited resource (to avoid force-evolving stains of bacteria that are resistant or immune).
At the end of the day, there's not as much research because there's a finite amount of resources to go around and there are easier / lower hanging fruit.